AMPAC Fine Chemicals Announces New President

[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]

AMPAC Fine Chemicals (AFC) is pleased to announce that Dr Jeff Butler has been promoted to the position of President, AMPAC Fine Chemicals.

AMPAC Fine Chemicals (AFC) is pleased to announce that Dr Jeff Butler has been promoted to the position of President, AMPAC Fine Chemicals. Dr Butler has performed in leadership roles of increasing responsibility with his most previous position being Vice President of Project Management. In his new role, Dr Butler is responsible for operations across all AFC US-based facilities.

“Jeff has been very instrumental in the growth of AFC. His technical leadership coupled with his business acumen will allow him to further lead AFC’s success as our US Operations continue their swift expansion” said Dr Aslam Malik, CEO of SK pharmteco, the parent company of AFC.

Jeff holds a PhD in Chemistry from the University of California, Davis and conducted his Post-Doctoral research in Chemistry at the University of Texas at Austin. Jeff will continue to operate out of AFC’s Rancho Cordova, CA facilities. AMPAC FINE CHEMICALS LLC AFC is a US-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients and registered intermediates for pharmaceutical and biotechnology customers. AFC is a portfolio company of SK pharmteco, a US-based Contract Development and Manufacturing Organization (CDMO) with multiple operations in Korea, Ireland and the US.[/et_pb_text][/et_pb_column] [/et_pb_row] [/et_pb_section]
AMPAC Fine Chemicals Announces New President